Kailong Li

799 citations
32 papers · 586 indexed · h-index 10
Topics
Chronic Kidney Disease and Diabetes (4 papers)Renal Diseases and Glomerulopathies (3 papers)Cancer Genomics and Diagnostics (3 papers)

In The Last Decade

Kailong Li

29 papers receiving 575 citations

Peers

Kailong Li
Comparison fields: 5 of 84
  • Nephrology 229
  • Molecular Biology 183
  • Physiology 90
  • Epidemiology 86
  • Pulmonary and Respiratory Medicine 58
Replace Shiqun Sun with:
Shiqun Sun China
Angela Koudijs Netherlands
Shaobin Duan China
Guohua Ding China
Shan Zhu China
Keiji Okuda Japan
Tatiana Novitskaya United States
Jaime Ibarrola Spain
Shuangping Zhao China
Kailong Li relative to Shiqun Sun China Shiqun Sun's profile →
Citations per field
00.5×6.5×
Shiqun Sun · 1×
Citations per year

Countries citing papers authored by Kailong Li

Since Specialization
Citations

This map shows the geographic impact of Kailong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailong Li more than expected).

Fields of papers citing papers by Kailong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kailong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailong Li. The network helps show where Kailong Li may publish in the future.

Co-authorship network of co-authors of Kailong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kailong Li. A scholar is included among the top collaborators of Kailong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kailong Li. Kailong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 1
5 29
6 0
7 0
8 3
9 9
10 6
11 9
12 4
13 13
14 6
15 122
16 6
17 39
18 54
19
[Effect of p53 on the variation of renal tubular epithelial cells after kidney ischemia/reperfusion injury].
1
20 164

About Kailong Li

Kailong Li is a scholar working on Nephrology, Clinical Biochemistry and Cancer Research, having authored 32 papers that have together received 586 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Nephrology (229 citations), Critical Care and Intensive Care Medicine (41 citations) and Clinical Biochemistry (43 citations). Kailong Li has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Yani He, Jurong Yang, Hanlu Ding, Jianguo Zhang, Xiaolin Li, Wenda Gao, Rong Lü, Kehong Chen, Limin Wang and Jia Chen. Their work appears in journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026